vs
LivaNova PLC（LIVN）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是LivaNova PLC的1.9倍（$682.8M vs $360.9M），LivaNova PLC净利率更高（8.6% vs -4.8%，领先13.4%），LivaNova PLC同比增速更快（12.1% vs -0.4%），Rackspace Technology, Inc.自由现金流更多（$56.0M vs $50.2M），过去两年LivaNova PLC的营收复合增速更高（10.6% vs -0.6%）
LivaNova PLC是一家深耕医疗设备领域的企业，总部位于英国，核心业务为研发心脏外科及神经调控类医疗设备。该公司由美国Cyberonics公司与意大利Sorin公司于2015年以27亿美元对价合并成立，目前在纳斯达克挂牌交易，股票代码为LIVN。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
LIVN vs RXT — 直观对比
营收规模更大
RXT
是对方的1.9倍
$360.9M
营收增速更快
LIVN
高出12.6%
-0.4%
净利率更高
LIVN
高出13.4%
-4.8%
自由现金流更多
RXT
多$5.8M
$50.2M
两年增速更快
LIVN
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $360.9M | $682.8M |
| 净利润 | $30.9M | $-32.7M |
| 毛利率 | 65.2% | 17.6% |
| 营业利润率 | 11.8% | -0.5% |
| 净利率 | 8.6% | -4.8% |
| 营收同比 | 12.1% | -0.4% |
| 净利润同比 | -44.7% | 41.6% |
| 每股收益（稀释后） | $0.57 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LIVNRXT
| Q4 25 | $360.9M | $682.8M | ||
| Q3 25 | $357.8M | $671.2M | ||
| Q2 25 | $352.5M | $666.3M | ||
| Q1 25 | $316.9M | $665.4M | ||
| Q4 24 | $321.8M | $685.6M | ||
| Q3 24 | $318.1M | $675.8M | ||
| Q2 24 | $318.6M | $684.9M | ||
| Q1 24 | $294.9M | $690.8M |
净利润LIVNRXT
| Q4 25 | $30.9M | $-32.7M | ||
| Q3 25 | $26.8M | $-67.1M | ||
| Q2 25 | $27.2M | $-54.5M | ||
| Q1 25 | $-327.3M | $-71.5M | ||
| Q4 24 | $55.9M | $-56.0M | ||
| Q3 24 | $33.0M | $-186.6M | ||
| Q2 24 | $16.3M | $25.0M | ||
| Q1 24 | $-41.9M | $-640.6M |
毛利率LIVNRXT
| Q4 25 | 65.2% | 17.6% | ||
| Q3 25 | 68.4% | 19.4% | ||
| Q2 25 | 67.8% | 19.4% | ||
| Q1 25 | 69.7% | 19.1% | ||
| Q4 24 | 68.2% | 19.2% | ||
| Q3 24 | 70.8% | 20.3% | ||
| Q2 24 | 68.7% | 19.2% | ||
| Q1 24 | 70.3% | 19.2% |
营业利润率LIVNRXT
| Q4 25 | 11.8% | -0.5% | ||
| Q3 25 | 15.1% | -5.1% | ||
| Q2 25 | 15.4% | -3.8% | ||
| Q1 25 | 15.3% | -5.8% | ||
| Q4 24 | 11.5% | -4.2% | ||
| Q3 24 | 11.2% | -25.7% | ||
| Q2 24 | 12.6% | -7.9% | ||
| Q1 24 | 5.5% | -94.5% |
净利率LIVNRXT
| Q4 25 | 8.6% | -4.8% | ||
| Q3 25 | 7.5% | -10.0% | ||
| Q2 25 | 7.7% | -8.2% | ||
| Q1 25 | -103.3% | -10.7% | ||
| Q4 24 | 17.4% | -8.2% | ||
| Q3 24 | 10.4% | -27.6% | ||
| Q2 24 | 5.1% | 3.7% | ||
| Q1 24 | -14.2% | -92.7% |
每股收益（稀释后）LIVNRXT
| Q4 25 | $0.57 | $-0.13 | ||
| Q3 25 | $0.49 | $-0.28 | ||
| Q2 25 | $0.50 | $-0.23 | ||
| Q1 25 | $-6.01 | $-0.31 | ||
| Q4 24 | $1.04 | $-0.20 | ||
| Q3 24 | $0.60 | $-0.82 | ||
| Q2 24 | $0.30 | $0.11 | ||
| Q1 24 | $-0.78 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.6M | $105.8M |
| 总债务越低越好 | $376.1M | $2.7B |
| 股东权益账面价值 | $1.2B | $-1.2B |
| 总资产 | $2.6B | $2.8B |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资LIVNRXT
| Q4 25 | $635.6M | $105.8M | ||
| Q3 25 | $646.1M | $99.5M | ||
| Q2 25 | $593.6M | $103.9M | ||
| Q1 25 | $738.4M | $128.0M | ||
| Q4 24 | $428.9M | $144.0M | ||
| Q3 24 | $346.4M | $157.1M | ||
| Q2 24 | $329.2M | $190.2M | ||
| Q1 24 | $309.2M | $282.6M |
总债务LIVNRXT
| Q4 25 | $376.1M | $2.7B | ||
| Q3 25 | $434.5M | $2.8B | ||
| Q2 25 | $430.6M | $2.8B | ||
| Q1 25 | $628.2M | $2.8B | ||
| Q4 24 | $627.0M | $2.8B | ||
| Q3 24 | $625.5M | $2.8B | ||
| Q2 24 | $624.5M | $2.9B | ||
| Q1 24 | $623.8M | $3.0B |
股东权益LIVNRXT
| Q4 25 | $1.2B | $-1.2B | ||
| Q3 25 | $1.2B | $-1.2B | ||
| Q2 25 | $1.1B | $-1.1B | ||
| Q1 25 | $1.0B | $-1.1B | ||
| Q4 24 | $1.3B | $-1.0B | ||
| Q3 24 | $1.3B | $-949.7M | ||
| Q2 24 | $1.2B | $-756.2M | ||
| Q1 24 | $1.2B | $-787.2M |
总资产LIVNRXT
| Q4 25 | $2.6B | $2.8B | ||
| Q3 25 | $2.6B | $2.8B | ||
| Q2 25 | $2.5B | $2.9B | ||
| Q1 25 | $2.6B | $3.0B | ||
| Q4 24 | $2.5B | $3.1B | ||
| Q3 24 | $2.5B | $3.1B | ||
| Q2 24 | $2.5B | $3.4B | ||
| Q1 24 | $2.5B | $3.5B |
负债/权益比LIVNRXT
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.4M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $50.2M | $56.0M |
| 自由现金流率自由现金流/营收 | 13.9% | 8.2% |
| 资本支出强度资本支出/营收 | 8.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.67× | — |
| 过去12个月自由现金流最近4个季度 | $173.3M | $90.6M |
8季度趋势，按日历期对齐
经营现金流LIVNRXT
| Q4 25 | $82.4M | $59.7M | ||
| Q3 25 | $85.1M | $70.7M | ||
| Q2 25 | $62.9M | $8.4M | ||
| Q1 25 | $24.0M | $12.6M | ||
| Q4 24 | $78.7M | $54.3M | ||
| Q3 24 | $51.0M | $51.8M | ||
| Q2 24 | $43.4M | $24.1M | ||
| Q1 24 | $10.0M | $-90.3M |
自由现金流LIVNRXT
| Q4 25 | $50.2M | $56.0M | ||
| Q3 25 | $62.2M | $42.7M | ||
| Q2 25 | $47.8M | $-12.4M | ||
| Q1 25 | $13.2M | $4.3M | ||
| Q4 24 | $68.3M | $34.4M | ||
| Q3 24 | $32.8M | $27.3M | ||
| Q2 24 | $31.2M | $-14.5M | ||
| Q1 24 | $3.6M | $-118.4M |
自由现金流率LIVNRXT
| Q4 25 | 13.9% | 8.2% | ||
| Q3 25 | 17.4% | 6.4% | ||
| Q2 25 | 13.6% | -1.9% | ||
| Q1 25 | 4.2% | 0.6% | ||
| Q4 24 | 21.2% | 5.0% | ||
| Q3 24 | 10.3% | 4.0% | ||
| Q2 24 | 9.8% | -2.1% | ||
| Q1 24 | 1.2% | -17.1% |
资本支出强度LIVNRXT
| Q4 25 | 8.9% | 0.5% | ||
| Q3 25 | 6.4% | 4.2% | ||
| Q2 25 | 4.3% | 3.1% | ||
| Q1 25 | 3.4% | 1.2% | ||
| Q4 24 | 3.2% | 2.9% | ||
| Q3 24 | 5.7% | 3.6% | ||
| Q2 24 | 3.8% | 5.6% | ||
| Q1 24 | 2.2% | 4.1% |
现金转化率LIVNRXT
| Q4 25 | 2.67× | — | ||
| Q3 25 | 3.18× | — | ||
| Q2 25 | 2.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.41× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 2.65× | 0.96× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
